Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 606, Issue 1-3, Pages 38-44Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejphar.2009.01.030
Keywords
siRNA; Hexitol; Altritol; Chemical modification; B-Raf; Stability
Categories
Funding
- NIH [PO1 GM59299]
Ask authors/readers for more resources
increasing the effectiveness of siRNAs through chemical modification is an important task. Here we describe altritol and hexitol modified oligonucleotides targeting the B-Raf oncogene that is critical for the growth and survival of melanoma cells. Using assays for apoptosis, DNA synthesis, colony formation and B-Raf protein and message levels, we demonstrate that certain hexitol modifications can improve the effectiveness of B-Raf siRNAs and also increase duration of action. Altritol modified siRNAs were similar to or slightly less effective than unmodified B-Raf siRNA. Modifications at the 3' or 5' end of the sense strand, at the 3' end of the antisense strand, or within either strand were well tolerated. The basis for the increased effectiveness of the hexitol-modified siRNAs is not fully understood but may be partly due to increased stability to nucleases. (C) 2009 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available